BRENDA BRECHLER: Open Payments
NPI 1346354743 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,094 in 11 payments from 6 companies in 2025. Trend: 2023 $5,095 · 2024 $1,701 · 2025 $1,094
Food & beverage: $1,094
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $488 |
| ABBVIE INC. | 1 | $148 |
| Gilead Sciences, Inc. | 1 | $130 |
| KYOWA KIRIN, INC. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $108 |
| Regeneron Healthcare Solutions, Inc. | 1 | $98 |
Products named: BREZTRI, QULIPTA, AIRSUPRA, Epclusa, TEZSPIRE, REXULTI, DUPIXENT.
Industry payments across NV — which companies pay providers there.
